Vimarsana
Biggest News Aggregation in the World

Quadria Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quadria Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quadria Capital Today - Breaking & Trending Today

Meet 10 new speakers at Asia PE-VC Summit 2024 - Super Saver Tickets Extended! - Vimarsana News

Meet 10 new speakers at Asia PE-VC Summit 2024 - Super Saver Tickets Extended!

Our new speakers operate across geographies including Greater China, India, Southeast Asia and the Middle East.

Health insurance, nutrition are areas of high interest for us: Quadria Capital - Vimarsana News

Health insurance, nutrition are areas of high interest for us: Quadria Capital

Quadria, which is currently raising an $800-million fund to invest in healthcare opportunities across India and Asia, has assets under management of $1.4 billion in India.

Quadria Capital picks up stake in Indian dialysis chain NephroPlus for $102m - Vimarsana News

Quadria Capital picks up stake in Indian dialysis chain NephroPlus for $102m

NephroPlus operates about 450 dialysis centres in three main countries namely India, the Philippines and Uzbekistan.

Dialysis firm NephroPlus gets 8,50 crore from Quadria - Vimarsana News

Dialysis firm NephroPlus gets 8,50 crore from Quadria

India Business News: New Delhi: Singapore-based healthcare-focused PE firm Quadria Capital has announced an investment of $102 million (Rs 850 crore) in NephroPlus, Asia's.

NephroPlus: Quadria cap picks up minority stake in NephroPlus - Vimarsana News

NephroPlus: Quadria cap picks up minority stake in NephroPlus

NephroPlus, India's largest dialysis chain, has secured $103 million (₹860 crore) in a Series F funding round led by Quadria Capital. This funding, a mix of fresh capital and a secondary sale, aims to drive expansion plans within India and targeted markets overseas. The primary component of the funding is ₹100 crore. Quadria Capital will become a minority shareholder, valuing NephroPlus at over ₹2,000 crore. Existing investors like Bessemer Venture Partners, International Finance Corporation, and IIFL also participated in the funding round, reducing their stakes.